Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 12, Number 2—February 2006

Research

Methicillin-resistant Staphylococcus aureus Clones, Western Australia

Geoffrey W. Coombs*†, Julie C. Pearson*, Frances G. O'Brien†, Ronan J. Murray*, Warren B. Grubb†, and Keryn J. Christiansen*†Comments to Author 
Author affiliations: *Royal Perth Hospital, Perth, Western Australia, Australia; †Curtin University of Technology, Bentley, Western Australia, Australia

Main Article

Table A1

Community MRSA antibiogram*. Download as PDF [61 KB, 3 pages].

ST
1
M
R
S
A
IV ST
129
M
R
S
A
IV ST
5
M
R
S
A
IV ST
45
M
R
S
A
V ST
8
M
R
S
A
IV ST
93
M
R
S
A
IV ST
75
M
R
S
A
IV ST
59
M
R
S
A
V ST
573
M
R
S
A
V ST
5
M
R
S
A
V ST
584
M
R
S
A
IV ST
59
M
R
S
A
IV ST
8
M
R
S
A
nov ST
583
M
R
S
A
IV ST
5
M
R
S
A
nov ST
609
M
R
S
A
IV ST
5
M
R
S
A
nov ST
577
M
R
S
A
V ST
45
M
R
S
A
IV ST
87
M
R
S
A
IV ST
575
M
R
S
A
IV ST
30
M
R
S
A
IV T
O
T
A
L %
β-lactam resistance only (44.05%)
O
1107
16
139
53
11
29
9




3


1

2

1

1
28
1400
44.05
β-lactam plus 1 non– β-lactam antimicrobial drug resistance (45.06%)
O, E
213
883
87
4
4
5




1






3

1


1201
37.79
O, F
132
1
3
1




2













139
4.37
O, C
29

4
1
1

















35
1.10
O, Tp
17
1
3

4

















25
0.79
O, Tc
10

1
1
1

















13
0.41
O, G


2






11












13
0.41
O, M
3





















3
0.09
O, R
1




















2
3
0.09
β-lactam plus 2 non–β-lactam antimicrobial drug resistance (9.44%)
O, E, F
179
4
1










1








185
5.82
O, E, C
3
18
16

6

















43
1.35
O, E, Tc
17
3


1


3














24
0.76
O, E, Tp
1
14




















15
0.47
O, G, Tp
8

2



















10
0.31
O, Tp, M
5

2



















7
0.22
O, E, R

5




















5
0.16
O, G, M
1

3



















4
0.13
O, E, M
1
1




















2
0.06
O, T, F
1












1








2
0.06
O, G, F
1





















1
0.03
O, G, C
1





















1
0.03
O, C, M












1









1
0.03
β-lactam plus 3 non–β-lactam antimicrobial drug resistance (0.98%)
O, E, TpR G
9

1

1

















11
0.35
O, E, G, M


4



















4
0.13
O, E, C, F
3





















3
0.09
O, Tc, F, M
1








2












3
0.09
O, E, Tp, M,
2
1




















3
0.09
O, E, C, M


1

1

















2
0.06
O, E, Tc, M,
1





















1
0.03
O, E, C, Tc


1



















1
0.03
O, E, C, Tp


1



















1
0.03
O, Tp, G, M
1





















1
0.03
O, Tc, G, M
1





















1
0.03
β-lactam plus 4 non–β-lactam antimicrobial drug resistance (0.38%)
O, E, Tc, F, M
6








1












7
0.22
O, E, C, Tc, G


2



















2
0.06
O, E, Tc, F, Tp









1












1
0.03
O, E, Tp, G, R




1

















1
0.03
O, E, F, M, G
1





















1
0.03
β-lactam plus 5 non–β-lactam antimicrobial drug resistance (0.09%)
O, E, C, F, M, G















1






1
0.03
O, E, C, F, M, Tp
1





















1
0.03
O, E, C, F, Tc, Tp
1





















1
0.03
TOTAL 1757 947 273 60 31 34 9 3 2 15 1 3 1 2 1 1 2 3 1 1 1 30 3178

*MRSA, methicillin-resistant Staphylococcus aureus; O, oxacillin; Tc, tetracycline; E, erythromycin; Tp, trimethoprim; C, ciprofloxacin; G, gentamicin; F, fusidic acid; R, rifampin; M, mupirocin; nov, novel.

Main Article

TOP